Home›Pulmonology & Critical Care› Retrospective cohort study of 74 patients with Chlamydia psittaci pneumonia identifies prognostic indicators and severity associations
Retrospective cohort study of 74 patients with Chlamydia psittaci pneumonia identifies prognostic indicators and severity associationsIs your pneumonia severe? New data shows specific signs that mean longer hospital stays
Frontiers in MedicinePublished April 6, 2026Study authors: Yanyan Li, Hongyi Zhu, Zijie Zhan, Ge Li, Quan Zhou, Chao Zheng, Fan HuangDOI ↗Editorial oversight: Dr. Amelia Tan, PhD · Internal Medicine & Chronic Disease
AI-generated summary of the cited source, checked by automated accuracy review.
How we work
Share
Key Takeaway
Note that severe CPP associates with prolonged hospitalization and specific imaging; D-dimer and lymphocyte % may aid severity assessment.
This retrospective cohort study analyzed the clinical course and prognostic factors in 74 patients diagnosed with Chlamydia psittaci pneumonia (CPP) via metagenomic (mNGS) and targeted next-generation sequencing (tNGS). The study compared clinical manifestations, laboratory findings, and imaging characteristics between non-severe and severe CPP groups to identify predictors of disease severity and outcomes. The specific setting and follow-up duration were not reported in the available data.
The analysis revealed that hospitalization duration was significantly longer in the severe group compared to the non-severe group, with a mean of 12.95 ± 6.08 days versus 8.13 ± 3.30 days (p < 0.05). Additionally, prolonged hospitalization, bilateral pulmonary infiltrates, and pleural effusion were identified as clinical features associated with severe CPP. While specific absolute numbers for these associations were not reported, the statistical significance of the hospitalization duration difference was noted.
Regarding prognostic indicators, the study highlighted that D-dimer levels and lymphocyte percentage are valuable for assessing disease severity. However, the study did not explicitly state a single primary outcome, focusing instead on comparing clinical features and prognostic factors between the two severity groups. Safety data, including adverse events or tolerability, were not reported in the provided evidence.
Key limitations include the retrospective study design, the unspecified single-center or setting, and a lack of information regarding external validation or generalizability. As an observational study, the results may be subject to confounding and bias inherent in retrospective designs. Consequently, causal relationships between the identified clinical features and disease severity cannot be definitively established based on this evidence alone.
In terms of practice relevance, the study suggests that while early targeted antibiotic therapy is effective, timely respiratory support remains critical for severe cases. Clinicians should interpret these findings with caution, recognizing that the associations identified require further prospective validation before they can be integrated into standard diagnostic or prognostic algorithms for CPP.
Getting the right diagnosis for pneumonia is hard because symptoms often look the same for many different infections. This study focused on Chlamydia psittaci pneumonia, a specific type caused by a bacteria found in birds. Doctors used advanced genetic testing to identify the infection in 74 patients. They then compared those with mild illness to those with severe illness to see what made the difference.
Patients with severe pneumonia stayed in the hospital significantly longer than those with milder cases. The study found that severe illness was linked to fluid around the lungs and shadows on both sides of the lungs seen on scans. Doctors also noted that certain blood markers, like D-dimer and lymphocyte percentage, could help predict how sick a patient might get.
However, this study has important limits. It was a look back at past records, which can introduce errors or missed details. We do not know if these findings apply to patients in other hospitals or regions. While early treatment with antibiotics works well, knowing which patients are at risk for severe disease is critical for getting them the right support quickly.
What this means for you:
Severe pneumonia shows specific lung signs and longer hospital stays, but this early study needs more testing.
Study Details
Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
Chlamydia psittaci pneumonia (CPP) is frequently misdiagnosed and can progress to severe illness. A deeper understanding of its clinical and imaging features is crucial for early detection and effective treatment.
This retrospective study analyzed 74 patients diagnosed with CPP via metagenomic (mNGS) and targeted next-generation sequencing (tNGS) between January 2022 and September 2025. Patients were categorized into severe (n = 21) and non-severe (n = 53) groups based on established criteria for severe community-acquired pneumonia. Data on demographics, clinical manifestations, laboratory findings, and imaging characteristics were collected and compared.
The cohort had a median age of 60 years, with a male predominance (62.2%). A history of poultry/bird exposure was reported by 87.8% of participants. Common symptoms included fever (94.6%), cough (63.5%), and fatigue (29.7%), with no significant differences between groups. Hospitalization was significantly longer in the severe group (12.95 ± 6.08 days) than in the non-severe group (8.13 ± 3.30 days) (p
Severe CPP is associated with prolonged hospitalization, bilateral pulmonary infiltrates, and pleural effusion. D-dimer and lymphocyte percentage are valuable prognostic indicators for disease severity. Early targeted antibiotic therapy is effective, but timely respiratory support is critical for severe cases.
